Skip to main content
. 2014 Dec;58(12):7416–7423. doi: 10.1128/AAC.03851-14

FIG 4.

FIG 4

Potency of HCV NS3 protease (ASV) and NS5A replication complex (DCV) inhibitors on BMS-791325-resistant replicon cell lines. GT1 and GT3 to -6 NS5B wild-type (WT) and BMS-791325 resistant (R) replicon cell lines were tested for sensitivity to HCV inhibitors BMS-791325, ASV, and DCV. EC50s are the averages from at least 2 independent experiments, and error bars represent standard deviations.